UTMD EBITDA Growth
Utah Medical Products Inc · EBITDA Growth
UTMD EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-16.87%period ending
UTMD TTM EBITDA YoY % (185.71% → -16.87%)
Year-over-year change
High-resolution chart · PNG
UTMD ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -16.872% | |
| -8.8849% | |
| -12.5986% | |
| -18.8943% | |
| -21.1003% | |
| -26.4319% | |
| -25.7479% | |
| -24.7529% | |
| -20.285% | |
| -13.0845% | |
| -7.5905% | |
| 1.0907% | |
| 3.3534% | |
| 4.6174% | |
| 5.9812% | |
| 7.2289% | |
| 13.9926% | |
| 28.3494% | |
| 25.8176% | |
| 19.4329% | |
| 8.0382% | |
| -14.8955% | |
| -14.7295% | |
| -7.2553% | |
| 0.6648% | |
| 14.772% | |
| 13.2822% | |
| 4.6255% | |
| -1.2678% | |
| -3.0783% | |
| -0.7335% | |
| 5.519% | |
| 10.7168% | |
| 14.0834% | |
| 14.3599% | |
| 7.5958% | |
| 2.8305% | |
| 0.946% | |
| 1.2582% | |
| 0.7858% | |
| 1.3908% | |
| -0.978% | |
| -3.1865% | |
| 1.6022% | |
| 4.0668% | |
| 7.2955% | |
| 7.4438% | |
| 4.9559% | |
| 0.9872% | |
| -0.5328% | |
| -1.8748% | |
| 0.6648% | |
| 4.7415% | |
| 5.6897% | |
| 25.4418% | |
| 33.8518% | |
| 53.5257% | |
| 78.3946% | |
| 52.0935% | |
| 34.8085% | |
| 13.5431% | |
| -3.9877% | |
| -5.3337% | |
| 0.772% | |
| -3.4887% | |
| -7.7093% | |
| -6.9568% | |
| -13.7097% | |
| -6.932% | |
| -2.7143% | |
| -3.2764% | |
| -0.5579% | |
| -2.8502% | |
| -2.8031% | |
| -1.0027% | |
| 5.1802% | |
| 12.691% | |
| 15.5651% | |
| 15.6966% | |
| 8.441% | |
| -3.6876% | |
| -7.5818% | |
| -9.205% | |
| -10.778% | |
| -7.4863% | |
| -6.9432% | |
| -6.7316% | |
| -4.3039% | |
| -3.681% | |
| -2.1851% | |
| -0.0683% | |
| -15.4525% | |
| -13.4303% | |
| -13.3363% | |
| -13.6836% | |
| 24.7247% | |
| 24.9659% | |
| 26.2415% | |
| 28.5498% | |
| 4.4019% |